Pfizer Drafts A New “Org Chart” Post Wyeth Merger
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer to appoint a number of key Wyeth execs to prominent positions post-merger, sending a clear signal that it is handling the integration of Wyeth differently from its previous acquisitions of Pharmacia and Warner Lambert.
You may also be interested in...
Sanofi-Aventis' New R&D Model Aims To Build A Network For Innovation
Anticipated reorganization seems to mimic previous actions by Big Pharma, with an emphasis on external collaboration and a move to smaller, independent groups..
Sanofi-Aventis' New R&D Model Aims To Build A Network For Innovation
Anticipated reorganization seems to mimic previous actions by Big Pharma, with an emphasis on external collaboration and a move to smaller, independent groups..
Glaxo and Pfizer Form An HIV Company; Spin-Off Next?
Two companies join forces to create a stronger HIV presence than either could mount alone, but the real upside comes if they can spin out the unnamed entity.